Overview
The February 14th scan captured 258 total 20-week breakout signals, with a slight bearish tilt showing 137 bearish versus 121 bullish signals. This 53-47 bearish-to-bullish ratio suggests modest caution in intermediate-term momentum, though the market remains fairly balanced. More concerning is the quality of these breakouts: the bullish leaders are dominated by leveraged ETFs and ETNs with minimal institutional backing, while high-volatility small-caps show extreme risk metrics. Only EVMN and FGL represent actual operating companies with significant upside from 52-week lows, limiting actionable opportunities for momentum traders seeking institutional validation.
Top 5 Bullish Picks
EVMN ($31.57) — Medical/Biomed-Biotech
Weekly Momentum: EVMN stands out as the only quality operational play among today’s breakouts, surging 127.4% from its 52-week low and now trading just 4.9% below its 52-week high. The biotech posted exceptional volume at 2.7x average with 1.36 million shares traded, confirming institutional participation. The ATR multiple of 3.87 indicates a powerful extended move beyond normal volatility ranges. As a recent IPO (bucket_0_youth), EVMN demonstrates classic early-stage biotech momentum, though the 14.8% ADR warns of significant daily swings.
| Level | Price | Calculation |
|---|---|---|
| Current Price | $31.57 | — |
| Stop Loss (2 ATR) | $24.69 | $31.57 – (2 × $3.44) |
| Target 1 (1.5 ATR) | $36.73 | $31.57 + (1.5 × $3.44) |
| Target 2 (3 ATR) | $41.89 | $31.57 + (3 × $3.44) |
| 52W High Distance | $33.20 | 4.9% upside |
Institutional Interest: Zero reported institutional funds, typical for youth IPOs where institutional data lags. The 44.1% LOD risk suggests substantial downside if momentum breaks.
FGL ($18.00) — Energy/Solar
Weekly Momentum: This solar play exploded with 27.7x relative volume (1.43 million vs. 52K average), the strongest volume surge in today’s scan. FGL has rallied 156.1% from its 52-week low but remains 88.9% below its high, indicating potential recovery from severe oversold conditions. The negative ATR multiple of -2.72 despite being a percentage breakout suggests pullback into support. With 23.3% ADR and 118.5% LOD risk, this is an extremely volatile trade suitable only for aggressive accounts.
| Level | Price | Calculation |
|---|---|---|
| Current Price | $18.00 | — |
| Stop Loss (2 ATR) | $9.24 | $18.00 – (2 × $4.38) |
| Target 1 (1.5 ATR) | $24.57 | $18.00 + (1.5 × $4.38) |
| Target 2 (3 ATR) | $31.14 | $18.00 + (3 × $4.38) |
| 52W Low Distance | 156.1% | Strong recovery |
Institutional Interest: Zero funds reported. Another recent IPO (bucket_0_youth) with massive speculation but no institutional validation.
GDXU ($347.25) — Materials/ETF
Weekly Momentum: GDXU leads dollar-based breakouts, crossing the $20 weekly threshold with an astonishing 855.4% gain from 52-week lows. This leveraged gold miner ETF shows extreme moves typical of 2-3x leveraged products. The -0.12 ATR multiple indicates consolidation near highs, while 15.7% ADR reflects the leveraged nature. Still 35.8% below its 52-week high suggests room to run if gold continues strength. Volume matched average at 756K shares, showing steady institutional ETF flow rather than retail speculation.
| Level | Price | Calculation |
|---|---|---|
| Current Price | $347.25 | — |
| Stop Loss (2 ATR) | $238.25 | $347.25 – (2 × $54.50) |
| Target 1 (1.5 ATR) | $429.00 | $347.25 + (1.5 × $54.50) |
| Target 2 (3 ATR) | $510.75 | $347.25 + (3 × $54.50) |
| 52W High Distance | $541.00 | 35.8% upside |
Institutional Interest: Zero dedicated funds hold this leveraged ETF, normal for 2-3x products used tactically.
VRTL ($94.99) — Industrials/ETF
Weekly Momentum: VRTL posted a massive 5.90 ATR multiple move with an extraordinary 1,154.8% surge from its 52-week low. This industrials-focused ETF now sits just 15.7% below its high, indicating a nearly complete recovery. However, volume came in at just 0.6x average (61K shares), raising concerns about sustainability. The $9.71 ATR creates wide stop levels requiring substantial capital allocation.
| Level | Price | Calculation |
|---|---|---|
| Current Price | $94.99 | — |
| Stop Loss (2 ATR) | $75.57 | $94.99 – (2 × $9.71) |
| Target 1 (1.5 ATR) | $109.56 | $94.99 + (1.5 × $9.71) |
| Target 2 (3 ATR) | $124.12 | $94.99 + (3 × $9.71) |
| 52W High Distance | $112.70 | 15.7% upside |
Institutional Interest: No dedicated fund ownership typical for niche sector ETFs.
FRMI ($10.29) — Energy/Alternative
Weekly Momentum: Leading the percentage breakout list, FRMI shows 43.3% recovery from 52-week lows despite remaining 72.2% below its high. Volume surged to 1.6x average with 11.4 million shares traded, strong for a $10 stock. The negative -0.70 ATR multiple indicates profit-taking after an extended run. The 25.1% LOD risk and 9.8% ADR suggest manageable daily volatility compared to other energy plays.
| Level | Price | Calculation |
|---|---|---|
| Current Price | $10.29 | — |
| Stop Loss (2 ATR) | $8.31 | $10.29 – (2 × $0.99) |
| Target 1 (1.5 ATR) | $11.78 | $10.29 + (1.5 × $0.99) |
| Target 2 (3 ATR) | $13.26 | $10.29 + (3 × $0.99) |
| 52W High Recovery | 72.2% | Still deeply discounted |
Institutional Interest: Zero institutional funds, limiting validation for this alternative energy play.
Bearish Alerts
The bearish breakdown list is led by HTFL ($20.66), a medical software company with significant institutional backing (148 funds) now testing 20-week support. Trading 49.9% below its 52-week high with a -2.36 ATR multiple and 2.5x volume, HTFL represents genuine institutional distribution. This is the only bearish name with institutional credibility, making it a key sector warning for healthcare technology.
The remaining bearish signals—AFRU, SMU, LABX, and UPSX—are all leveraged ETFs/ETNs with zero institutional ownership, sitting 77-96% below their highs. These represent failed leveraged trades rather than sector warnings.
Sector Themes
Today’s breakouts show Energy and Materials leading with FRMI, FGL, and GDXU capturing the alternative energy and precious metals rally. The dominance of ETF/ETN products (7 of top 10) rather than individual stocks suggests sector rotation via baskets rather than stock-specific momentum. Healthcare shows a singular bright spot with EVMN’s biotech breakout, while the HTFL breakdown warns of software weakness. Financials appear on both sides via ETFs, indicating internal sector divergence rather than directional conviction.
Institutional Summary
Institutional participation remains alarmingly weak across today’s breakouts. Only EVMN, FGL, ORCX (1 fund), and the bearish HTFL (148 funds) show any institutional presence. The absence of fund accumulation in 9 of 10 bullish leaders suggests retail-driven momentum in leveraged products rather than smart-money validation. For institutional-focused strategies, HTFL’s bearish breakdown with 148 funds merits more attention than the bullish list, signaling potential healthcare tech sector rotation away from medical software.